https://www.novumpr.nl/2017/10/03/seattle-genetics-and-takeda-announce-publication-in-blood-of-final-long-term-survival-data-from-adcetris-brentuximab-vedotin-pivotal-phase-2-clinical-trial-in-relapsed-or-refractory-systemic-a/?utm_source=rss&utm_medium=rss&utm_campaign=seattle-genetics-and-takeda-announce-publication-in-blood-of-final-long-term-survival-data-from-adcetris-brentuximab-vedotin-pivotal-phase-2-clinical-trial-in-relapsed-or-refractory-systemic-a NovumPR press releases Tue, 03 Oct 2017 12:24:48 +0000 hourly 1 https://wordpress.org/?v=6.8.2